AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
6,951.50
-155.00 (-2.18%)
Aug 31, 2026, 3:30 PM IST
AstraZeneca Pharma India Employees
AstraZeneca Pharma India had 600 employees as of June 30, 2026. The number of employees decreased by 160 or -21.05% since the number was last reported on March 31, 2026.
Employees
600
Change
-160
Growth
-21.05%
Revenue / Employee
32.00M INR
Profits / Employee
2.23M INR
Market Cap
174.27B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 600 | -160 | -21.05% |
| Mar 31, 2026 | 760 | -42 | -5.24% |
| Mar 31, 2025 | 802 | -138 | -14.68% |
| Mar 31, 2024 | 940 | -7 | -0.74% |
| Mar 31, 2023 | 947 | -236 | -19.95% |
| Mar 31, 2022 | 1,183 | -100 | -7.79% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alembic Pharmaceuticals | 17,244 |
| Akums Drugs and Pharmaceuticals | 7,337 |
| Piramal Pharma | 7,120 |
| Emcure Pharmaceuticals | 6,731 |
| NATCO Pharma | 4,199 |
| Strides Pharma Science | 3,535 |
| Eris Lifesciences | 3,354 |
| Wockhardt | 2,564 |
AstraZeneca Pharma India News
- 21 days ago - AstraZeneca Pharma India Quarterly report: Q1 2027 - Filings
- 2 months ago - AstraZeneca Pharma India appoints Mihir Parikh and Amay Ashok Pandey to key director roles - Business Upturn
- 2 months ago - AstraZeneca Pharma India appoints Praveen K Mittal as Director - Corporate Affairs - Business Upturn
- 2 months ago - AstraZeneca Pharma India announces resignation of senior management personnel - Business Upturn
- 2 months ago - AstraZeneca gets CDSCO approval to sell Enhertu in India for first-line HER2-positive breast cancer treatment - Business Upturn
- 3 months ago - Why are AstraZeneca Pharma shares down over 4% today? Explained - Business Upturn
- 3 months ago - AstraZeneca Pharma India Quarterly report: Q4 2026 - Filings
- 3 months ago - AstraZeneca Pharma India Annual report: Q4 2026 - Filings